ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,037.88
0.72%
US Tech 100
20,978.80
0.00%
다우존스 지수
44,556.04
0.30%
Bitcoin
97,855.00
-0.01%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 캐나다
  5. TSXV

  6. Rakovina Therapeutics Inc (RKV) 시세

Rakovina Therapeutics Inc

Rakovina Therapeutics Inc (RKV)

TSXV
0.215
0.025
(13.16%)
마감 05 2월 6:00AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
0.215
매수가
0.205
매도가
0.215
거래량
368,838
0.18 일간 변동폭 0.22
0.005 52주 범위 0.23
market_cap
15.068M
전일 종가
0.19
개장가
0.19
최근 거래 시간
1000
@
0.215
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
300,125
발행 주식
70,084,000
배당수익률
-
주가수익률
-5.36
주당순이익(EPS)
-0.04
매출
-
순이익
-2.61M

Rakovina Therapeutics Inc 정보

섹터
Unit Inv Tr, Closed-end Mgmt
산업
Unit Inv Tr, Closed-end Mgmt
웹사이트
www.rakovinatherapeutics.com
본부
Vancouver, British Columbia, Can
설립됨
-
Rakovina Therapeutics Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the TSX 벤처 거래소 with ticker RKV. The last closing price for Rakovina Therapeutics was $0.19. Over the last year, Rakovina Therapeutics shares have traded in a share price range of $ 0.005 to $ 0.23.

Rakovina Therapeutics currently has 70,084,000 shares in issue. The market capitalisation of Rakovina Therapeutics is $13.32 million. Rakovina Therapeutics has a price to earnings ratio (PE ratio) of -5.36.

RKV 최신 뉴스

추가 뉴스

Rakovina Therapeutics Announces Listing on Frankfurt Stock Exchange

VANCOUVER, British Columbia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel...

31 1월 2025
GlobeNewswire Inc.

Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer therapies through artificial...

29 1월 2025
GlobeNewswire Inc.

Rakovina Therapeutics Comments on $500 Billion AI Infrastructure Investment and Its Implications for Healthcare Innovation

VANCOUVER, British Columbia, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company at the forefront of AI-driven drug discovery, yesterday...

22 1월 2025
GlobeNewswire Inc.

Rakovina Therapeutics Announces Key Milestone in Cancer Drug Innovation in Collaboration with Variational AI

VANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel...

13 1월 2025
GlobeNewswire Inc.

Rakovina Therapeutics Announces Receipt of AI-Derived Drug Candidates and Advancement to Preclinical Validation

VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company focused on the development of new cancer therapies based on...

06 1월 2025
GlobeNewswire Inc.

Rakovina Therapeutics to Connect with Industry Leaders During 43rd Annual J.P. Morgan Healthcare Conference Week

VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics, Inc. (TSX: RKV), a biopharmaceutical company focused on the development of new cancer therapies based on...

04 1월 2025
GlobeNewswire Inc.

Rakovina Therapeutics: Reflecting on 2024 Success and Building Momentum for a Transformative 2025

VANCOUVER, British Columbia, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) a biopharmaceutical company focused on the development of new...

19 12월 2024
GlobeNewswire Inc.

Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations

VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) announces that in accordance with the terms of an indenture...

18 12월 2024
GlobeNewswire Inc.

Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement

VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”, “Rakovina”, or “Rakovina Therapeutics”) a biopharmaceutical company...

14 12월 2024
GlobeNewswire Inc.

Rakovina Therapeutics Announces Presentation at the 13th Annual Tumour Models London Summit

VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new...

03 12월 2024
GlobeNewswire Inc.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.014.878048780490.2050.220.171900920.19359258CS
40.02513.15789473680.190.230.153270750.20018604CS
120.135168.750.080.230.0453001250.14731098CS
260.12126.3157894740.0950.230.0451684760.13586911CS
520.125138.8888888890.090.230.0051093560.12573508CS
1560.02513.15789473680.190.250.005465040.12952478CS
260-0.035-140.250.3950.005460670.14432885CS

RKV - Frequently Asked Questions (FAQ)

What is the current Rakovina Therapeutics share price?
The current share price of Rakovina Therapeutics is $ 0.215
How many Rakovina Therapeutics shares are in issue?
Rakovina Therapeutics has 70,084,000 shares in issue
What is the market cap of Rakovina Therapeutics?
The market capitalisation of Rakovina Therapeutics is CAD 13.32M
What is the 1 year trading range for Rakovina Therapeutics share price?
Rakovina Therapeutics has traded in the range of $ 0.005 to $ 0.23 during the past year
What is the PE ratio of Rakovina Therapeutics?
The price to earnings ratio of Rakovina Therapeutics is -5.36
What is the reporting currency for Rakovina Therapeutics?
Rakovina Therapeutics reports financial results in CAD
What is the latest annual profit for Rakovina Therapeutics?
The latest annual profit of Rakovina Therapeutics is CAD -2.61M
What is the registered address of Rakovina Therapeutics?
The registered address for Rakovina Therapeutics is 720,999 WEST BROADWAY, VANCOUVER, BRITISH COLUMBIA, V5Z1K5
What is the Rakovina Therapeutics website address?
The website address for Rakovina Therapeutics is www.rakovinatherapeutics.com
Which industry sector does Rakovina Therapeutics operate in?
Rakovina Therapeutics operates in the UNIT INV TR, CLOSED-END MGMT sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ROCKEros Resources Corp
 0.06
(300.00%)
644.88k
NICKNickelex Resource Corporation
$ 0.01
(100.00%)
161k
TVITVI Pacific Inc
$ 0.01
(100.00%)
150k
PORPortofino Resources Inc
$ 0.01
(100.00%)
240k
FUNDKatipult Technology Corp
$ 0.01
(100.00%)
20k
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
2.18M
NZPChatham Rock Phosphate Limited
$ 0.055
(-35.29%)
9k
FEXFjordland Exploration Inc
$ 0.01
(-33.33%)
40k
HBKHighbank Resources Ltd
$ 0.01
(-33.33%)
35k
SCLTSearchlight Resources Inc
$ 0.01
(-33.33%)
242k
WGOWhite Gold Corp
$ 0.20
(17.65%)
11.26M
GPUSAlset AI Ventures Inc
$ 0.115
(15.00%)
4.47M
OMIOrosur Mining Inc
$ 0.19
(65.22%)
4.45M
BRCBlackrock Silver Corp
$ 0.355
(9.23%)
2.48M
XBOTRealbotix Corp
$ 0.48
(-4.00%)
2.41M

토론

전체 피드 보기
Stino2 Stino2 5 분 전
The following company's did a RS and have sunk very deep: BNGO, MULLEN, JAGX, ADAP, OCGN, NKLA etc....🤑
ADAP BNGO JAGX
Stino2 Stino2 9 분 전
25% I have left and also this company doesn't answer their mails!!😪
TNXP
Stino2 Stino2 10 분 전
We wil see today???
TNXP
Biotechotcguy Biotechotcguy 16 분 전
This is getting juicy!!!!!
DROR
infamous infamous 20 분 전
so much for compliance again. what a trap this is
GCTK
misterfishman misterfishman 23 분 전
Agreed.
IGPK
bbotcs bbotcs 28 분 전
al44: That should result in a lawsuit.
bbotcs bbotcs 30 분 전
lj: SMCI
Has it finally bottomed, or will it retest the recent low of $25 and change? Stay tuned.
Thank you for mentioning the AMD calls. Will check them out today (Wednesday).
AMD SMCI
leavetheguntakethecannolis leavetheguntakethecannolis 31 분 전
A reminder for all.

https://www.beam-med.com/

Brain

Epilepsy is the most prevalent serious neurologic condition in the world, affecting about 70 million people. Unfortunately, 30%-40% of those patients are afflicted with drug resistant epilepsy, meaning t
IPIX
muee88 muee88 32 분 전
You’re welcome, no problem at all
NWBO
p0 p0 32 분 전
World’s First Chikungunya Vaccine, IXCHIQ
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®


February
VALN
bbotcs bbotcs 32 분 전
lj; mid-40s with a brisk breeze barely felt like the mid-30's!
bbotcs bbotcs 34 분 전
lj: Oil price was down on Tuesday morning but the big oil stocks were up!
DJPele DJPele 36 분 전
Much appreciated Muee! Although I did trust your initial post, it does help seeing it's full contents.
NWBO
CaptainObvious CaptainObvious 41 분 전
Something is, that's for sure
NWBO
zino zino 42 분 전
Great advice...if we get the right Quant Merger this will explode and could turn into a
potential Nasdaq uplisting...Just look at Rgti and its run Quant related and they're raising money so easily to the tune of 15O Million...was a penny stock few months back
GCAN
pgsd pgsd 46 분 전
Typical for anything related to DCVax lol

It is included in the list of Proposed 24-25 HC Drugs:

In the alphabetic order from the list it is listed as 'Brain cancer vaccine' which is then crossed out and Murcidencel is added...

https://investorshub.advfn
NWBO
muee88 muee88 47 분 전
Also, the Proposed 24-25 HC drug list is alphabetical, but Murcidencel is listed under the Bs because “Brain Cancer Vaccine” is crossed out and replaced with Murcidencel.
NWBO
TurboMountain96 TurboMountain96 47 분 전
Frankly, we are the original MEGA, Make Elite Great Again. We had that slogan long before Trump entered politics or plagiarized from Ronald Reagan, who originally started Make America Great Again. So to that end, maybe to support the stockholders, our MEGA, we’re going to build a wall of needle move
ELTP
RichieBoy RichieBoy 48 분 전
Only stating the patently obvious here...

When AFFU's dilution stops, the share price contraction stops. Just that simple. I get a strong sense the company is intentionally stalling for that reason. Mike Balkin and AFFU's other board member(s?) don't want to waste material event comp
AFFU
OnTrack444 OnTrack444 49 분 전

Is this your newest made pump account with a 122 followers on X?   😂   Total comedy 🎭 

How much do they pay you to pump bloated pigs because you cer
HMBL
muee88 muee88 52 분 전
Unfortunately, I don’t know how to upload a screenshot to this antiquated website —it shouldn’t be this difficult. I can assure you I’m not lying. Also, an email can be faked too so I’m not really sure what a screenshot would tell you.

However, here’s essentially the full text of the
NWBO
123tom 123tom 55 분 전
Steve, what you're saying about AVXL price movement not holding the support levels you'd expect... that's something I've watched AVXL do for 14 years. It's what I call the "bleeding down game". I always expect to see lower lows than we ought to see. Even in bullish upwave patterns.... the seller
AVXL
muee88 muee88 58 분 전
You need to click the tap entitled “Proposed 24-25 HC drugs.” On my phone, the tab I’m talking about is shown across the top of the website.
NWBO
skitahoe skitahoe 1 시간 전
When I use your link I get a list of their hospitals, not drugs, am I doing something wrong, or is there a problem with the link.

Thanks,

Gary
NWBO

최근 히스토리

TSXV
RKV
Rakovina Therapeutics
NASDAQ
FBKQX
Agf Floating Rate Income...
NASDAQI
FTLB
First Trust Low Beta Inc...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지